OBJECTIVE	A Phase I study to assess the single and multipledose pharmacokinetics ( PKs ) and safety and tolerability of oromucosally administered ( 9 ) - tetrahydrocannabinol ( THC ) / cannabidiol ( CBD ) spray , an endocannabinoid system modulator , in healthy male subjects .\